Diagnos Inc New (DGNOF) 0.0609 $DGNOF
DIAGNOS Appoints New Executive Chairman & Announces Concurrent Private Placement
Marketwired - Tue Jun 30, 1:18PM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces both the appointment of Lloyd M. Segal as Executive Chairman of the board of directors of the Corporation and that it has entered into an engagement agreement for a private placement ("Private Placement"

consisting of Senior Secured Convertible Debentures (each a "Debenture"

, having a 4-year term and bearing interest at an annual rate of 10% for gross proceeds of up to $4,000,000, on a best efforts basis. Philip Renaud, Diagnos' current Chairman, will continue to serve as a director of the Corporation and investment funds associated with Mr. Renaud have placed a lead order in the Private Placement.
ADK.VN: 0.080 (+0.010)
DIAGNOS Announces Industry Leading Performance of its Automated Dark Lesion Detection for Diabetic Retinopathy Screening
Marketwired - Tue Jun 16, 8:30AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, is pleased to announce the leading results for the automated detection of dark lesions (microaneurysms and bleeding) related to the presence of diabetic retinopathy.
ADK.VN: 0.080 (+0.010)
DIAGNOS Announces a Strategic Alliance With the Largest Private Hospital Group in Latin America to Unburden Diabetes in the Public Health System
Marketwired - Wed May 27, 8:31AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a strategic alliance with Centro Diagnostico Angeles.
ADK.VN: 0.080 (+0.010)
DIAGNOS Inc.: DARC Chooses CARA for a Clinical Trial in Conjunction with a Top Five Pharmaceutical Company in the United States
Marketwired - Tue May 19, 8:24AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today an agreement with Digital Angiography Reading Center (DARC).
ADK.VN: 0.080 (+0.010)
DIAGNOS Announces Licensing Deal With Inb al Haythem Center in Algeria
Marketwired - Mon May 04, 8:31AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a licensing deal with Inb al Haythem Center in Algeria.
ADK.VN: 0.080 (+0.010)
DIAGNOS Announces Licensing Deal With Clinique Hamouche in Algeria
Marketwired - Tue Apr 14, 8:04AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a deal with Clinique Hamouche in Algeria.
ADK.VN: 0.080 (+0.010)
DIAGNOS Announces Retina Screening Project with Clinique Chifa Hydra in Algeria
Marketwired - Thu Apr 09, 9:52AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today a retina screening project with Clinique Chifa Hydra in Algeria.
ADK.VN: 0.080 (+0.010)
Alexandria Review of Cadillac Break Property Geophysics Yields Strong Targets
Marketwired - Wed Apr 01, 8:16AM CDT
Alexandria Minerals Corporation (TSX VENTURE: AZX)(FRANKFURT: A9D) ("Alexandria" or the "Company"

is pleased to announce the results of a statistical study of the Company's geophysical data on its Cadillac Break Property package in Val d'Or, Quebec. The study, carried out by Diagnos Inc. of Montreal, covered the entire length of the Company's 35 km long property, and provides several solid drill targets over the length of the property.
AZX.VN: 0.040 (unch)
DIAGNOS Announces Two Year Renewal of Successful Program in the UAE
Marketwired - Thu Mar 26, 8:48AM CDT
Diagnos Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today a renewal of the agreement originally announced on March 14th 2012 that has since been renewed and expanded to a total of fourteen mobile screening units. The value of the two year agreement is approximately 716,000 CAD.
ADK.VN: 0.080 (+0.010)
DIAGNOS Announces First Screening Project in Poland with Globally Leading Pharmaceutical Company
Marketwired - Wed Mar 18, 11:58AM CDT
DIAGNOS Inc. ("DIAGNOS" or "the Corporation"

(TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announced today the signing of a contract with a large global pharmaceutical company that markets a leading ophthalmology product indicated for a variety of ophthalmic complications, including those associated with diabetes, for a screening project in Poland. This project is in conjunction with the same global pharmaceutical company that DIAGNOS works with around the world, including the UAE and India.
ADK.VN: 0.080 (+0.010)